Skip to main content

Thermo Fisher Scientific Inc.

TMO
Exchange
NYSE
Industry
Measuring & Controlling Devices, NEC
SEC CIK
0000097745

In the last 90 days, Thermo Fisher Scientific Inc. insiders filed 0 open-market purchases and 11 sales; 2,627 institutions reported holding it in 13F filings for Q2 2026, worth $169.2B in total; 6 superinvestors hold it, including Viking Global Investors and D1 Capital Partners.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $61.6M in total
11
13F holdersQ2 2026, +52 vs. previous quarter
2,627
13F valueReported value at the end of Q2 2026
$169.2B
Superinvestors holdingAt the end of Q2 2026
6

Price chart

Superinvestors holding TMO, Q2 2026

6 superinvestors report holding Thermo Fisher Scientific Inc. on Form 13F. Percentages are the stock's share of each portfolio.

Go to the superinvestors tab

Viking Global Investors

Andreas Halvorsen

2.8%

Thermo Fisher Scientific Inc.'s share of the portfolio

Shares
1,937,415
Value
$971.3M

D1 Capital Partners

Dan Sundheim

1.2%

Thermo Fisher Scientific Inc.'s share of the portfolio

Shares
817,123
Value
$409.7M
Other superinvestors holding TMO (part 1)
SuperinvestorWeightValue
Lindsell Train9.8%$258.0M
Weitz Investment Management4.0%$57.8M
Markel Group0.3%$36.6M
Duquesne Family Office0.2%$9.63M

Latest insider trades

Open-market purchases and sales by Thermo Fisher Scientific Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 1, 2026 (view filing)4:10 PM ETAug 311 dayPettiti GianlucaPresident & COOSSale−4.13K$614.38−$2.54M−15.1%23.2K after2 lots10b5-1
Aug 26, 2026 (view filing)4:01 PM ETAug 242 daysCasper Marc NChairman & CEOSSale−275$627.05−$172.4K−0.2%123.9K after4 lots10b5-1
Aug 24, 2026 (view filing)4:02 PM ETAug 20-214 daysCasper Marc NChairman & CEOSSale−20.0K$628.09−$12.6M−13.9%123.9K after14 lots10b5-1
Aug 20, 2026 (view filing)4:02 PM ETAug 191 dayBritt Lisa P.Sr. VP and Chief HR OfficerSSale−11.4K$613.12−$7.01M−43.6%14.8K after
Aug 13, 2026 (view filing)4:01 PM ETAug 112 daysShafer Michael DExecutive Vice PresidentSSale−25.5K$600.00−$15.3M−54.8%21.0K after2 lots10b5-1
Aug 10, 2026 (view filing)4:09 PM ETAug 73 daysHolmes Joseph R.VP & Chief Accounting OfficerSSale−420$584.81−$245.6K−12.4%2.97K after
Aug 10, 2026 (view filing)4:09 PM ETAug 73 daysCasper Marc NChairman & CEOSSale−275$586.10−$161.2K−0.2%123.9K after15 lots10b5-1
Aug 10, 2026 (view filing)4:09 PM ETAug 73 daysCasper Marc NChairman & CEOSSale−4.61K$586.12−$2.70M−100.0%0 after12 lots10b5-1
Aug 7, 2026 (view filing)5:32 PM ETAug 61 dayBritt Lisa P.Sr. VP and Chief HR OfficerSSale−5.85K$580.00−$3.39M−28.4%14.8K after
Aug 7, 2026 (view filing)5:26 PM ETAug 61 dayCasper Marc NChairman & CEOSSale−10.0K$574.47−$5.74M−7.5%123.9K after9 lots10b5-1

Top 10 13F holders, Q2 2026

The largest institutional positions in Thermo Fisher Scientific Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 2,627 holders
Institutions holding TMO in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.30,919,632$15.5B0.23%+492,440+1.6%Added
Vanguard Capital Management LLC24,276,316$12.2B0.26%−4,5000.0%Reduced
State Street Corp16,825,879$8.44B0.25%+94,211+0.6%Added
FMR LLC14,084,488$7.06B0.31%+3,308,052+30.7%Added
Morgan Stanley10,763,066$5.40B0.29%−100,462−0.9%Reduced
JPMorgan Chase & Co8,503,527$4.31B0.25%+1,708,045+25.1%Added
Geode Capital Management, LLC8,382,401$4.18B0.22%−25,490−0.3%Reduced
Franklin Resources Inc7,271,514$3.65B0.79%+458,483+6.7%Added
Vanguard Portfolio Management LLC6,226,169$3.12B0.14%+62,799+1.0%Added
Capital World Investors6,195,370$3.11B0.37%−450,946−6.8%Reduced